Business
On Monday, NewLink Genetics announced it has made a deal with drug maker Merck, to research, develop, manufacture and distribute an experimental Ebola vaccine,...
Hi, what are you looking for?
On Monday, NewLink Genetics announced it has made a deal with drug maker Merck, to research, develop, manufacture and distribute an experimental Ebola vaccine,...
Israel’s Cell Source Inc., an immunotherapy and regenerative medicine company, announced that its Megadose Drug Combination which assists in bone marrow transplants has been...
– The Opko Health Chairman hopes to attain a value of over $100 million for the Rehovot-based vaccination developer. Vaccination company SciGen, controlled...
– Perrigo is expanding its reach into Europe through a $3.1 billion acquisition of one of the continent’s biggest suppliers of non-prescription medicines....
– Intec Pharma says it expects the Phase III trial for its Accordion Pill Levodopa to take place in the second half of 2015....
– The project brings together a consortium of parties from Israel, Jordan, and Switzerland for the treatment of the parasitic disease. – Researchers from...
– Leading Israeli Pharmaceutical company Teva has mixed results in its initial U.S. Supreme Court hearing over the possible loss of patent protection for...
– Smallcap investor network report: An experimental Ebola drug can be produced on Protalix‘s vegetable platform. Anxiety about the Ebola disease increased again at...
Israeli drug companies, such as Teva, are pretty good at producing imitation drugs quickly. Teva was truly disruptive to big pharma companies, since they...
BrainStorm Cell Therapeutics, an Israeli developer of adult stem cell technologies for neurodegenerative diseases, announced that the US Food and Drug Administration has designated...